0.6298
price down icon5.26%   -0.035
pre-market  Pre-mercato:  .64   0.0102   +1.62%
loading

Biofrontera Inc Borsa (BFRI) Ultime notizie

pulisher
04:50 AM

Actinic Keratosis Treatment Market SWOT Analysis by Leading Expert: Almirall, Biofrontera, Nestle - newstrail.com

04:50 AM
pulisher
Jun 04, 2025

Biofrontera secures patent for Ameluz formulation until 2043 By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

biofrontera inc. revises proxy statement disclosure By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

biofrontera inc. revises proxy statement disclosure - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Biofrontera Updates Proxy Statement for 2025 Meeting - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Biofrontera Glycol-Free Skin Gel Added to FDA 'Orange Book;' Shares Rise - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Biofrontera Inc. (BFRI) Propylene Glycol-Free Patent Gains FDA Recognition | BFRI Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Biofrontera announces inclusion of patent in FDA Orange Book - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Biofrontera Inc. Announces Patent for Propylene Glycol-Free - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Biofrontera Secures 18-Year Patent Protection for Allergen-Free Ameluz Formula in FDA Orange Book - Stock Titan

Jun 03, 2025
pulisher
May 31, 2025

Biofrontera stock hits 52-week low at $0.58 amid market challenges By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

Biofrontera stock hits 52-week low at $0.58 amid market challenges - Investing.com India

May 30, 2025
pulisher
May 27, 2025

Biofrontera AG Faces Financial Uncertainty Amid Biofrontera Inc. Payment Issues - TipRanks

May 27, 2025
pulisher
May 23, 2025

Biofrontera Receives Nasdaq Non-Compliance Notice - TipRanks

May 23, 2025
pulisher
May 22, 2025

Roth Capital Decreases Earnings Estimates for Biofrontera - Defense World

May 22, 2025
pulisher
May 22, 2025

Q2 Earnings Forecast for Biofrontera Issued By Roth Capital - Defense World

May 22, 2025
pulisher
May 20, 2025

Biofrontera Inc. (NASDAQ:BFRI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 20, 2025
pulisher
May 20, 2025

Biofrontera (NASDAQ:BFRI) Price Target Lowered to $2.75 at Benchmark - Defense World

May 20, 2025
pulisher
May 19, 2025

Biofrontera, Inc. Earnings Call: Growth Amid Challenges - TipRanks

May 19, 2025
pulisher
May 19, 2025

Benchmark cuts Biofrontera stock target to $2.75, keeps Buy rating By Investing.com - Investing.com Nigeria

May 19, 2025
pulisher
May 19, 2025

Photodynamic Therapy Market Trends Report 2025-2033, Competitive Analysis of Gladerma, Sun Pharma, Biofrontera, Lumibird, Bausch Health, Soligenix, Modulight, and Theralase TechnologiesResearchAndMarkets.com - FinancialContent

May 19, 2025
pulisher
May 19, 2025

Biofrontera (BFRI) Sees Price Target Reduction by Benchmark | BF - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Benchmark cuts Biofrontera stock target to $2.75, keeps Buy rating - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Biofrontera (BFRI) Target Price Trimmed After Lower Revenue Perf - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Biofrontera Inc. price target lowered to $2.75 from $7 at Benchmark - TipRanks

May 19, 2025
pulisher
May 19, 2025

Biofrontera signals 2025 record revenue ambitions with new Ameluz patent and cost controls - MSN

May 19, 2025
pulisher
May 17, 2025

Biofrontera Inc. (BFRI) Reports 9% Revenue Growth in Q1 2025 - GuruFocus

May 17, 2025
pulisher
May 16, 2025

Earnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dips - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dips By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Transcript : Biofrontera Inc., Q1 2025 Earnings Call, May 16, 2025 - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

BFRI Increases Q1 Revenue and Expands Market Presence | BFRI Sto - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Biofrontera extends Ameluz patent to 2043 for acne treatment By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 15, 2025

Biofrontera Inc. reports Q1 EPS (47c) vs. ($2.88) last year - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. (BFRI) Sees Encouraging Revenue Growth in Q1 | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. (BFRI) Sees Encouraging Revenue Growth in Q1 | BFRI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. reports Q1 EPS (47c) vs. (71c) last year - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biofrontera (BFRI) Achieves Patent Approval and Advances Clinica - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera Announces New Patent Protection On Ameluz Until 2043 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Biofrontera (BFRI) Achieves Patent Approval and Advances Clinical Trials | BFRI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera's Revised Ameluz Formulation Receives US Patent Approval - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Biofrontera extends Ameluz patent to 2043 for acne treatment - Investing.com

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. announces patent protection on Ameluz until 2043 - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. faces Nasdaq delisting over share price By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 14, 2025

Biofrontera Inc. faces Nasdaq delisting over share price - Investing.com Australia

May 14, 2025
$8.59
price down icon 1.38%
drug_manufacturers_specialty_generic RDY
$14.75
price up icon 0.61%
$124.52
price down icon 0.38%
drug_manufacturers_specialty_generic HCM
$15.30
price up icon 4.08%
$323.97
price down icon 0.07%
$17.52
price up icon 1.92%
Capitalizzazione:     |  Volume (24 ore):